Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES VENUS REMEDIES DIVIS LABORATORIES/
VENUS REMEDIES
 
P/E (TTM) x 29.9 14.9 201.0% View Chart
P/BV x 7.6 0.6 1,248.4% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   VENUS REMEDIES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
VENUS REMEDIES
Mar-22
DIVIS LABORATORIES/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs5,425639 849.6%   
Low Rs3,562261 1,365.3%   
Sales per share (Unadj.) Rs337.5447.8 75.4%  
Earnings per share (Unadj.) Rs111.530.5 366.1%  
Cash flow per share (Unadj.) Rs123.355.5 221.9%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs441.8329.4 134.1%  
Shares outstanding (eoy) m265.4713.37 1,985.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.31.0 1,325.9%   
Avg P/E ratio x40.314.8 273.0%  
P/CF ratio (eoy) x36.58.1 450.4%  
Price / Book Value ratio x10.21.4 745.3%  
Dividend payout %26.90-   
Avg Mkt Cap Rs m1,192,8906,011 19,844.7%   
No. of employees `000NANA-   
Total wages/salary Rs m9,462523 1,808.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,5985,987 1,496.7%  
Other income Rs m1,15983 1,394.9%   
Total revenues Rs m90,7576,070 1,495.3%   
Gross profit Rs m38,811621 6,248.4%  
Depreciation Rs m3,115335 928.9%   
Interest Rs m205 415.8%   
Profit before tax Rs m36,835364 10,117.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,231-43 -16,752.8%   
Profit after tax Rs m29,605407 7,269.5%  
Gross profit margin %43.310.4 417.5%  
Effective tax rate %19.6-11.9 -165.6%   
Net profit margin %33.06.8 485.7%  
BALANCE SHEET DATA
Current assets Rs m96,1042,780 3,456.5%   
Current liabilities Rs m24,544927 2,646.6%   
Net working cap to sales %79.931.0 258.0%  
Current ratio x3.93.0 130.6%  
Inventory Days Days921 40.9%  
Debtors Days Days987235 419.6%  
Net fixed assets Rs m50,0873,011 1,663.5%   
Share capital Rs m531134 397.2%   
"Free" reserves Rs m116,7514,271 2,733.7%   
Net worth Rs m117,2824,404 2,662.8%   
Long term debt Rs m0387 0.0%   
Total assets Rs m146,1915,791 2,524.3%  
Interest coverage x1,842.876.7 2,402.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.0 59.3%   
Return on assets %20.37.1 284.8%  
Return on equity %25.29.2 273.0%  
Return on capital %31.47.7 408.1%  
Exports to sales %00-   
Imports to sales %19.70-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m17,676NA-   
Fx inflow Rs m78,4450-   
Fx outflow Rs m17,9530-   
Net fx Rs m60,4920-   
CASH FLOW
From Operations Rs m19,118410 4,662.8%  
From Investments Rs m-21,949-166 13,201.7%  
From Financial Activity Rs m-5,324-95 5,618.2%  
Net Cashflow Rs m-8,156144 -5,673.1%  

Share Holding

Indian Promoters % 51.9 41.8 124.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 1.1 3,201.8%  
FIIs % 15.4 1.1 1,362.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 58.2 82.5%  
Shareholders   379,257 22,015 1,722.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs VENUS REMEDIES Share Price Performance

Period Divis Laboratories VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 1.01% 1.87% 0.23%
1-Month -4.84% -6.21% 0.36%
1-Year -31.54% -54.03% -6.87%
3-Year CAGR 23.48% 108.18% 20.16%
5-Year CAGR 26.72% 14.04% 11.07%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.